Shukla Rajiv

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$61,805.35
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Shukla Rajiv

According to the SEC Form 4 filings, Shukla Rajiv, being in a position of

  1. Chairman and CEO at Carmell Therapeutics Corporation,
    оver the last 12 months, has bought 23577 shares for $61,805, and sold 0 shares,
    over all time since 2024-04-04, has bought 23577 shares for $61,805, and sold 0 shares.

The largest purchase of all time was on 2024-04-04 and amounted to 8680 shares of Carmell Therapeutics Corporation for $24,998.

Biography of Shukla Rajiv

No biography is available at this moment.

2024-06-06PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
2,100
0.0875%
$2.63$5,527-81.82%
2024-05-30PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
2,000
0.0792%
$2.50$5,000-80.2%
2024-05-28PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
20
0.0008%
$2.57$51-80.4%
2024-05-24PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
1,939
0.079%
$2.57$4,991-80.63%
2024-05-23PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
2,100
0.0831%
$2.50$5,250-80.08%
2024-05-22PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
4,051
0.1547%
$2.41$9,771-79.64%
2024-05-21PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
1,515
0.0573%
$2.39$3,616-78.42%
2024-05-20PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
1,172
0.0412%
$2.22$2,601-77.1%
2024-04-04PurchaseCarmell Therapeutics Corporation
CTCX
Chairman and CEO
8,680
0.3958%
$2.88$24,998-61.54%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.